Marcus Westerberg

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Part of Journal of the National Cancer Institute, p. 1142-1150, 2025

• DOI for Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Download full text (pdf) of Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of The Journal of the National Comprehensive Cancer Network, 2025

• DOI for Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Part of Journal of Clinical Epidemiology, 2024

• DOI for Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Download full text (pdf) of Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Forsberg, Anna; Westerberg, Marcus; Metcalfe, Chris; Steele, Robert et al.

Part of The Lancet Gastroenterology & Hepatology, p. 513-521, 2022

• DOI for Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Part of International Journal of Epidemiology, 2025

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Download full text (pdf) of Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trial

Sekiguchi, Masau; Westerberg, Marcus; Löwbeer, Christian; Forsberg, Anna

Part of Gastrointestinal Endoscopy, p. 391-399, 2025

• DOI for Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trial

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Part of Journal of the National Cancer Institute, p. 1142-1150, 2025

• DOI for Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Download full text (pdf) of Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Part of European Urology Open Science, p. 41-50, 2025

• DOI for Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Download full text (pdf) of Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of The Journal of the National Comprehensive Cancer Network, 2025

• DOI for Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Westerberg, Marcus; Holm, Lennart; Garmo, Hans; Stattin, Pär et al.

Part of International Journal of Epidemiology, 2025

• DOI for Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase
• Download full text (pdf) of Cohort Profile Update: The National Prostate Cancer Register of Sweden and PCBase

Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trial

Sekiguchi, Masau; Westerberg, Marcus; Löwbeer, Christian; Forsberg, Anna

Part of Gastrointestinal Endoscopy, p. 391-399, 2025

• DOI for Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trial

Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf; Robinson, David et al.

Part of Journal of the National Cancer Institute, p. 1142-1150, 2025

• DOI for Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study
• Download full text (pdf) of Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based study

Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Zelic, Renata; Westerberg, Marcus; Stattin, Pär; Garmo, Hans et al.

Part of European Urology Open Science, p. 41-50, 2025

• DOI for Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study
• Download full text (pdf) of Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Pros tate Cancer-specific Death in Sweden: A Population-based Cohort Study

Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Scilipoti, Pietro; Bratt, Ola; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of The Journal of the National Comprehensive Cancer Network, 2025

• DOI for Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Scandinavian journal of urology, p. 93-96, 2025

• DOI for Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Download full text (pdf) of Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Ventimiglia, Eugenio; Gedeborg, Rolf; Orrason, Andri Wilberg; Zaurito, Paolo et al.

Part of Scandinavian journal of urology, p. 105-107, 2025

• DOI for A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer
• Download full text (pdf) of A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer

Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade

Thomsen, Frederik F.; Westerberg, Marcus; Petersson, Rasmus D.; Bak, Rasmine et al.

Part of BJU International, p. 760-765, 2025

• DOI for Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade

Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Ventimiglia, Eugenio; Gedeborg, Rolf; Styrke, Johan; Wilberg Orrason, Andri et al.

Part of JAMA Network Open, 2025

• DOI for Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden
• Download full text (pdf) of Radical Treatment for Prostate Cancer in Men With Limited Life Expectancy in Sweden

Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Corsini, Christian; Scilipoti, Pietro; Orrason, Andri Wilberg; Gedeborg, Rolf et al.

Part of JNCI Cancer Spectrum, 2025

• DOI for Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance
• Download full text (pdf) of Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study

Wilberg Orrason, Andri; Scilipoti, Pietro; Garmo, Hans; Gedeborg, Rolf et al.

Part of Scandinavian journal of urology, p. 50-58, 2025

• DOI for Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study
• Download full text (pdf) of Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study

Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield

Bonander, Carl; Westerberg, Marcus; Chauca Strand, Gabriella; Forsberg, Anna et al.

Part of JNCI Cancer Spectrum, 2024

• DOI for Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield
• Download full text (pdf) of Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: inequities in diagnostic yield

Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study

Westerberg, Marcus; Ahlberg, Mats; Wilberg Orrason, Andri; Gedeborg, Rolf

Part of Scandinavian journal of urology, p. 207-209, 2024

• DOI for Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study
• Download full text (pdf) of Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Part of PLOS ONE, 2024

• DOI for Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Download full text (pdf) of Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Scilipoti, Pietro; Liedberg, Fredrik; Garmo, Hans; Wilberg Orrason, Andri et al.

Part of Scandinavian journal of urology, p. 98-103, 2024

• DOI for Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study
• Download full text (pdf) of Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostatectomy. A nationwide populationbased study

Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Corsini, Christian; Bergengren, Oskar; Carlsson, Stefan; Garmo, Hans et al.

Part of European Urology Oncology, p. 605-613, 2024

• DOI for Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide Study

Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Westerberg, Marcus; Garmo, Hans; Robinson, David; Stattin, Pär et al.

Part of Journal of Clinical Epidemiology, 2024

• DOI for Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial
• Download full text (pdf) of Target trial emulation using new comorbidity indices provided risk estimates comparable to a randomized trial

Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial

Westerberg, Marcus; Eriksson, Julia; Metcalfe, Chris; Löwbeer, Christian et al.

Part of Journal of Internal Medicine, p. 187-199, 2024

• DOI for Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial
• Download full text (pdf) of Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trial

The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Westerberg, Marcus; Holmberg, Lars; Ekbom, Anders; Metcalfe, Chris et al.

Part of Scandinavian Journal of Gastroenterology, p. 503-511, 2024

• DOI for The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial
• Download full text (pdf) of The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Part of JAMA Network Open, 2023

• DOI for Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Download full text (pdf) of Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Sekiguchi, Masau; Westerberg, Marcus; Ekbom, Anders; Hultcrantz, Rolf et al.

Part of Gastroenterology, p. 293-2950000, 2023

• DOI for Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Design considerations for observational studies of drugs for advanced cancer

Garcia-Albeniz, Xabier; Stattin, Pär; Westerberg, Marcus; Weinrib, Rachel et al.

Part of Pharmacoepidemiology and Drug Safety, p. 812-815, 2023

• DOI for Design considerations for observational studies of drugs for advanced cancer
• Download full text (pdf) of Design considerations for observational studies of drugs for advanced cancer

Estimation in discrete time coarsened multivariate longitudinal models

Westerberg, Marcus

Part of Statistical Methods in Medical Research, p. 806-819, 2023

• DOI for Estimation in discrete time coarsened multivariate longitudinal models
• Download full text (pdf) of Estimation in discrete time coarsened multivariate longitudinal models

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Part of Journal of Clinical Epidemiology, p. 22-30, 2023

• DOI for Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Download full text (pdf) of Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Stattin, Pär; Westerberg, Marcus; Lissbrant, Ingela Franck; Eriksson, Marie Hjälm et al.

Part of Clinical Genitourinary Cancer, p. 1070-107000000000, 2023

• DOI for Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
• Download full text (pdf) of Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Khoshkar, Yashar; Westerberg, Marcus; Adolfsson, Jan; Bill-Axelson, Anna et al.

Part of BJUI Compass, p. 173-183, 2022

• DOI for Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
• Download full text (pdf) of Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort

Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Wilberg Orrason, Andri; Westerberg, Marcus; Albertsen, Peter; Styrke, Johan et al.

Part of PLOS ONE, 2022

• DOI for Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy
• Download full text (pdf) of Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancy

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Lycken, Magdalena; Bergengren, Oskar; Drevin, Linda; Garmo, Hans et al.

Part of European Urology Open Science, p. 81-87, 2022

• DOI for Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
• Download full text (pdf) of Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Watch out for sticky diagnosis bias in older men with prostate cancer: Editorial comment to “Evidence of overestimating prostate cancer mortality in Estonia: a population-based study by Innos K et al.”

Bergengren, Oskar; Westerberg, Marcus

Part of Scandinavian journal of urology, p. 365-366, 2022

• DOI for Watch out for sticky diagnosis bias in older men with prostate cancer: Editorial comment to “Evidence of overestimating prostate cancer mortality in Estonia: a population-based study by Innos K et al.”

Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Ventimiglia, Eugenio; Bill-Axelson, Anna; Adolfsson, Jan; Aly, Markus et al.

Part of European Urology Open Science, p. 46-51, 2022

• DOI for Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data
• Download full text (pdf) of Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based Data

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Part of Scandinavian journal of urology, p. 169-175, 2022

• DOI for Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Download full text (pdf) of Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study

Sekiguchi, Masau; Westerberg, Marcus; Ekbom, Anders; Hultcrantz, Rolf et al.

Part of Journal of Gastroenterology and Hepatology, p. 2120-2130, 2022

• DOI for Detection rates of colorectal neoplasia during colonoscopies and their associated factors in the SCREESCO study

Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial

Strömberg, U.; Bonander, C.; Westerberg, Marcus; Levin, L.Å. et al.

Part of eClinicalMedicine, 2022

• DOI for Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial
• Download full text (pdf) of Colorectal cancer screening with fecal immunochemical testing or primary colonoscopy: An analysis of health equity based on a randomised trial

Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Forsberg, Anna; Westerberg, Marcus; Metcalfe, Chris; Steele, Robert et al.

Part of The Lancet Gastroenterology & Hepatology, p. 513-521, 2022

• DOI for Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Bergengren, Oskar; Westerberg, Marcus; Holmberg, Lars; Stattin, Pär et al.

Part of JAMA Network Open, 2021

• DOI for Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
• Download full text (pdf) of Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort

Simulation model of disease incidence driven by diagnostic activity

Westerberg, Marcus; Larsson, Rolf; Holmberg, Lars; Stattin, Pär et al.

Part of Statistics in Medicine, p. 1172-1188, 2021

• DOI for Simulation model of disease incidence driven by diagnostic activity
• Download full text (pdf) of Simulation model of disease incidence driven by diagnostic activity

Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Orrason, Andri Wilberg; Westerberg, Marcus; Garmo, Hans; Lissbrant, Ingela Franck et al.

Part of BJU International, p. 142-151, 2020

• DOI for Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden
• Download full text (pdf) of Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population-based study in Sweden

Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Westerberg, Marcus; Franck Lissbrant, Ingela; Damber, Jan Erik; Robinson, David et al.

Part of Acta Oncologica, p. 106-111, 2020

• DOI for Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study
• Download full text (pdf) of Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study

Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Thomsen, Frederik B.; Westerberg, Marcus; Garmo, Hans; Robinson, David et al.

Part of PLOS ONE, 2020

• DOI for Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study
• Download full text (pdf) of Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register study

Prostate cancer incidence, treatment and mortality: Empirical longitudinal register-based studies and methods for handling missing data

Westerberg, Marcus

2022

• Download full text (pdf) of Prostate cancer incidence, treatment and mortality: Empirical longitudinal register-based studies and methods for handling missing data

Modelling short and long term consequences of changes in diagnostic activity and treatment

Westerberg, Marcus

2020

• Download full text (pdf) of Modelling short and long term consequences of changes in diagnostic activity and treatment

Nationwide study of time trends in prostate cancer death over two decades

Lycken, Magdalena; Garmo, Hans; Westerberg, Marcus; Axen, Elin et al.

Different assumptions about missingness in registration of metastatic status have important implications for following trends in cancer presentation

Westerberg, Marcus; Beckman, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.